FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

PhRMA Comments on Drug Labeling Guidance

PhRMA suggests changes to an FDA revised draft guidance on the content and format of the Dosing and Administration section of drug labeling.

latest-news-card-1
Biologics

Janssen Vaccine Warning on Myocarditis/Pericarditis

FDA revises the fact sheets on Janssens Covid-19 vaccine to include a warning about reported adverse events that suggest increased risks of myocarditi...

latest-news-card-1
Medical Devices

FDA Clears Telehealth Respiratory Wheeze Detector

FDA clears a TytoCare 510(k) for its Tyto Insights for Wheeze Detection, an algorithm for use on the companys existing artificial intelligence-powered...

latest-news-card-1
Human Drugs

CGMP Violations at Formology Lab

FDA warns Chatsworth, CA-based Formology Lab about CGMP violations in its production of drugs as a contract manufacturer.

latest-news-card-1
Human Drugs

Objectionable Conditions at Avanti Study Site: FDA

FDA warns Houston, TX- based Dr. Maggie Jeffries/Avanti Anesthesiology about conducting a clinical investigation without a required IND.

Biologics

FDA Authorizes Pfizer Bivalent Vaccine for Young Children

FDA amends the emergency use authorization for the Pfizer-BioNTech Covid-19 bivalent vaccine and its use as a single booster dose to include children ...

latest-news-card-1
Human Drugs

Profounda Significant CGMP Violations

FDA warns Orlando, FL-based Profounda about CGMP violations in its production of finished drugs as a contract manufacturer.

latest-news-card-1
Biologics

House GOP Probes Covid Political Interference at FDA

House Select Subcommittee on the Coronavirus Pandemic Republican leaders ask FDA for communications and interviews relating to potential political int...

latest-news-card-1
Human Drugs

More Comments on Patent Office/FDA Collaboration

Four stakeholders provide additional information to the U.S. Patent and Trademark Office about its collaboration with FDA.

latest-news-card-1
Human Drugs

Characterizing MRD Data in Cancer Trials

FDAers in CDER and the Oncology Center of Excellence discuss the use of minimal residual disease (MRD) data in hematologic clinical trials and treatme...